Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Portola's recombinant factor Xa inhibitor antidote reverses rivaroxaban effects in vivo

Sep. 14, 2011

Pfizer synthesizes novel MAP kinase-activated protein kinase 2 inhibitors

Sep. 14, 2011

Korean study identifies new risk factors for vascular dementia and Alzheimer's disease

Sep. 13, 2011

Appetite-regulating hormone gene mutation linked to panic disorder

Sep. 13, 2011

Final data disclosed from randomized menatetrenone trial in hepatocellular carcinoma

Sep. 13, 2011

Long-term phase II data presented on eliglustat in type 1 Gaucher's disease

Sep. 13, 2011

New biomarker to predict clinical outcome of sorafenib-treated hepatocellular carcinoma

Sep. 12, 2011

Long-term safety of alipogene tiparvovec evaluated in patients with lipoprotein lipase deficiency

Sep. 12, 2011

Korean University links putative oncogene to development of hepatocellular carcinoma

Sep. 12, 2011

Genentech discloses new brain-penetrant PI3K inhibitors

Sep. 12, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026